116 related articles for article (PubMed ID: 36655868)
21. Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b.
Yang X; Wang X; Liu D; Yu L; Xue B; Shi H
Mol Endocrinol; 2014 Apr; 28(4):565-74. PubMed ID: 24597547
[TBL] [Abstract][Full Text] [Related]
22. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
23. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk.
Ho V; Ashbury JE; Taylor S; Vanner S; King WD
Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459
[TBL] [Abstract][Full Text] [Related]
24. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes.
Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S
Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
[TBL] [Abstract][Full Text] [Related]
26. Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression.
Wang J; Xu P; Hao Y; Yu T; Liu L; Song Y; Li Y
BMC Cancer; 2021 Aug; 21(1):914. PubMed ID: 34380460
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
28. Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene.
Peng H; Chen Y; Gong P; Cai L; Lyu X; Jiang Q; Wang J; Lu J; Yao K; Liu K; Li J; Li X
Oncotarget; 2016 Jun; 7(26):40025-40037. PubMed ID: 27223069
[TBL] [Abstract][Full Text] [Related]
29. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R
J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874
[TBL] [Abstract][Full Text] [Related]
30. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W
Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791
[TBL] [Abstract][Full Text] [Related]
31. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype.
Fang M; Ou J; Hutchinson L; Green MR
Mol Cell; 2014 Sep; 55(6):904-915. PubMed ID: 25219500
[TBL] [Abstract][Full Text] [Related]
32. MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
Zo RB; Long Z
J Cell Physiol; 2018 Jan; 234(1):464-474. PubMed ID: 29893409
[TBL] [Abstract][Full Text] [Related]
33. Circ_0000467 modulates malignant characteristics of colorectal cancer via sponging miR-651-5p and up-regulating DNMT3B.
Zou L; Zhan N; Wu H; Huang B; Cui D; Chai H
Nucleosides Nucleotides Nucleic Acids; 2023; 42(2):134-150. PubMed ID: 36067529
[TBL] [Abstract][Full Text] [Related]
34. Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
Li J; Su X; Dai L; Chen N; Fang C; Dong Z; Fu J; Yu Y; Wang W; Zhang H; Wang H; Ji Y; Liu Y; Cheng L; Shi G; Zhang S; Yang Y; Deng H
Carcinogenesis; 2020 Apr; 41(2):235-244. PubMed ID: 31802101
[TBL] [Abstract][Full Text] [Related]
35. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers.
Kanai Y; Ushijima S; Kondo Y; Nakanishi Y; Hirohashi S
Int J Cancer; 2001 Jan; 91(2):205-12. PubMed ID: 11146446
[TBL] [Abstract][Full Text] [Related]
36. Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?
Tse JWT; Jenkins LJ; Chionh F; Mariadason JM
Trends Cancer; 2017 Oct; 3(10):698-712. PubMed ID: 28958388
[TBL] [Abstract][Full Text] [Related]
37. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
38. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.
Song W; Li W; Li L; Zhang S; Yan X; Wen X; Zhang X; Tian H; Li A; Hu JF; Cui J
Oncotarget; 2015 Sep; 6(27):23764-75. PubMed ID: 26156017
[TBL] [Abstract][Full Text] [Related]
39. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]